-

Shareholder Alert: Robbins LLP is Investigating OneSpan Inc. (OSPN) for Shareholders

SAN DIEGO & CHICAGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating OneSpan Inc. (NASDAQ: OSPN) to determine whether certain OneSpan officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company. OneSpan and its subsidiaries design, develop, and market solutions for identity, security, and business productivity.

If you suffered a loss due to OneSpan Inc.'s misconduct, click here.

OneSpan Inc. (OSPN) Overstated its Revenue

OneSpan Inc. may have made false and misleading statements regarding the Company's internal policies and downplayed the likely negative impact on its profits. On August 4, 2020, OneSpan postponed its second quarter 2020 earnings release due to revenue recognition problems spanning from the first quarter of 2018 through the first quarter of 2020, "which caused overstatements of revenue." After market close on August 11, 2020, the Company announced that it would not be able to timely submit its SEC report for the quarter ending on June 30, 2020, that same quarter year-over-year revenues had declined, and withdrew its full year 2020 earnings guidance, which it had just confirmed one quarter earlier. On this news, the Company stock price fell almost 40% to close at $18.84 per share on August 12, 2020.

OneSpan Inc. (OSPN) Shareholders Have Options

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against OneSpan Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

REGENXBIO, Inc. Stockholders Should Contact Robbins LLP for Information About Leading the RGNX Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired REGENXBIO, Inc. (NASDAQ: RGNX) securities between February 9, 2022 and January 27, 2026. REGENXBIO is a clinical-stage biotechnology company providing gene therapies that deliver functional genes to cells with genetic defects in the United States. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800)...

Investor Notice: Robbins LLP Informs Investors of the Gemini Space Station, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gemini Space Station, Inc. (NASDAQ: GEMI) Class A common stock pursuant and/or traceable to the Company's September 12, 2025 initial public offering ("IPO"), and/or Gemini Space Station, Inc. securities between September 12, 2025 and February 17, 2026. Gemini was founded to develop and operate a cryptocurrency platform. For more information, s...

uniQure N.V. Stockholders Should Contact Robbins LLP for Information About Leading the QURE Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? September 24, 2025 – October 31, 2025 W...
Back to Newsroom